Angiotensin Receptor Blockers as an Alternative to Angiotensin-Converting Enzyme Inhibitors in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention

BACKGROUND: Angiotensin-converting enzyme inhibitors (ACEIs) are the first choice for the treatment of acute myocardial infarction (AMI), and angiotensin receptor blockers (ARBs) should be considered in patients intolerant to ACEIs. Although previous studies support the use of ARBs as an alternative...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Korean Med Sci
Autores principales: Lim, Sungmin, Choo, Eun Ho, Choi, Ik Jun, Ihm, Sang-Hyun, Kim, Hee-Yeol, Ahn, Youngkeun, Chang, Kiyuk, Jeong, Myung Ho, Seung, Ki-Bae
Formato: Artigo
Lenguaje:Inglês
Publicado: The Korean Academy of Medical Sciences 2019
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6875434/
https://ncbi.nlm.nih.gov/pubmed/31760711
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3346/jkms.2019.34.e289
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares